Benzinga | May 6, 2021 04:23PM EDT

Acceleron Pharma Q1 EPS $(1.05) Misses $(0.81) Estimate, Sales $24.76M Miss $28.89M Estimate

Acceleron Pharma (NASDAQ:XLRN) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.81) by 29.63 percent. This is a 10.53 percent decrease over losses of $(0.95) per share from the same period last year. The company reported quarterly sales of $24.76 million which missed the analyst consensus estimate of $28.89 million by 14.30 percent. This is a 469.98 percent increase over sales of $4.34 million the same period last year.